Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1963 5
1964 2
1965 6
1972 1
1974 1
1975 5
1976 1
1977 1
1978 3
1979 7
1980 6
1981 5
1982 5
1983 3
1984 11
1985 7
1986 7
1987 6
1988 16
1989 6
1990 6
1991 6
1992 16
1993 22
1994 22
1995 13
1996 13
1997 14
1998 19
1999 17
2000 28
2001 30
2002 35
2003 15
2004 12
2005 12
2006 14
2007 17
2008 14
2009 4
2010 3
2011 13
2012 29
2013 18
2014 9
2015 8
2016 25
2017 17
2018 12
2019 9
2020 8
2021 7
2022 3
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

572 results

Results by year

Filters applied: . Clear all
Page 1
Cryptotia.
Ohmori S, Takada H. Ohmori S, et al. Aesthetic Plast Surg. 1979 Dec;3(1):15-28. doi: 10.1007/BF01577833. Aesthetic Plast Surg. 1979. PMID: 24173970
Climber's knuckle excoriation.
Ohmori S, Sawada Y, Nakamura M. Ohmori S, et al. J Dermatol. 2018 Sep;45(9):e264-e265. doi: 10.1111/1346-8138.14301. Epub 2018 Mar 23. J Dermatol. 2018. PMID: 29572907 No abstract available.
Nivolumab in the treatment of malignant melanoma: review of the literature.
Mashima E, Inoue A, Sakuragi Y, Yamaguchi T, Sasaki N, Hara Y, Omoto D, Ohmori S, Haruyama S, Sawada Y, Yoshioka M, Nishio D, Nakamura M. Mashima E, et al. Among authors: ohmori s. Onco Targets Ther. 2015 Aug 6;8:2045-51. doi: 10.2147/OTT.S62102. eCollection 2015. Onco Targets Ther. 2015. PMID: 26273207 Free PMC article. Review.
Clinical evidence of pharmacokinetic changes in thalidomide therapy.
Nakamura K, Matsuzawa N, Ohmori S, Ando Y, Yamazaki H, Matsunaga T. Nakamura K, et al. Among authors: ohmori s. Drug Metab Pharmacokinet. 2013;28(1):38-43. doi: 10.2133/dmpk.dmpk-12-rv-089. Epub 2012 Nov 20. Drug Metab Pharmacokinet. 2013. PMID: 23165864 Free article. Review.
Drug eruption caused by secukinumab.
Shibata M, Sawada Y, Yamaguchi T, Ohmori S, Omoto D, Haruyama S, Yoshioka M, Okada E, Nakamura M. Shibata M, et al. Among authors: ohmori s. Eur J Dermatol. 2017 Feb 1;27(1):67-68. doi: 10.1684/ejd.2016.2900. Eur J Dermatol. 2017. PMID: 27748259 No abstract available.
Drug Eruption Caused by Rosuvastatin.
Oda T, Sawada Y, Yamaguchi T, Ohmori S, Haruyama S, Yoshioka M, Okada E, Nakamura M. Oda T, et al. Among authors: ohmori s. J Investig Allergol Clin Immunol. 2017;27(2):140-141. doi: 10.18176/jiaci.0136. J Investig Allergol Clin Immunol. 2017. PMID: 28398205 Free article. No abstract available.
Drug eruption caused by memantine.
Saito R, Sawada Y, Yamaguchi T, Ohmori S, Haruyama S, Yoshioka M, Okada E, Nakamura M. Saito R, et al. Among authors: ohmori s. Ann Allergy Asthma Immunol. 2017 Jul;119(1):89-90. doi: 10.1016/j.anai.2017.05.005. Ann Allergy Asthma Immunol. 2017. PMID: 28668245 No abstract available.
Allogeneic Hematopoietic Cell Transplantation for Juvenile Myelomonocytic Leukemia with a Busulfan, Fludarabine, and Melphalan Regimen: JPLSG JMML-11.
Sakashita K, Yoshida N, Muramatsu H, Ohtsuka Y, Watanabe K, Yabe M, Kakuda H, Honda Y, Watanabe T, Haba M, Ohmori S, Matsuda K, Yuza Y, Saito A, Horibe K, Adachi S, Manabe A. Sakashita K, et al. Among authors: ohmori s. Transplant Cell Ther. 2024 Jan;30(1):105.e1-105.e10. doi: 10.1016/j.jtct.2023.10.002. Epub 2023 Oct 7. Transplant Cell Ther. 2024. PMID: 37806448
572 results